ロード中...
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
Prostate cancer (PCa) is the second leading cause of cancer death in American men. Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a key therapeutic target for lethal castration-resistant PCa (CRPC). GATA2 is a pioneer transcription factor crucial for inducing...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880415/ https://ncbi.nlm.nih.gov/pubmed/33586682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI135465 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|